Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell CarcinomaAimin Jiang, Chen Cai, Juelan Ye et al.|Cells|2023Cited by 34
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant TherapyZhenjie Wu, Taile Jing, Riccardo Bertolo et al.|European Urology Oncology|2023Cited by 17
Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombusYufeng Gu, Wenquan Zhou, Yao Fu et al.|Frontiers in Oncology|2023Cited by 14
QPCT regulation by CTCF leads to sunitinib resistance in renal cell carcinoma by promoting angiogenesisTangliang Zhao, Wenquan Zhou, Yulin Zhou et al.|International Journal of Oncology|2021Cited by 14
RNA modification pattern‐based subtypes reveal heterogenous clinical outcomes and tumor immunity of clear cell renal cell carcinomaAimin Jiang, Linhui Wang, Zi‐jun Xu et al.|MedComm – Future Medicine|2023Cited by 9